Adult Vaccines Market Expansion to $34.19 Billion by 2029: Key Drivers and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the adult vaccines market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Adult Vaccines Market Today And What Will It Reach By 2029?

The adult vaccines market has shown substantial growth in recent years. Its valuation is expected to rise from $22.82 billion in 2024 to $24.21 billion in 2025, driven by a compound annual growth rate (CAGR) of 6.1%. The expansion observed in the past can be ascribed to an expanding aging population, government vaccination programs, increasing awareness of preventive healthcare, ongoing vaccine development and innovation, and various public health campaigns.

The adult vaccines market is projected to experience substantial growth in the upcoming years, with its size anticipated to reach $34.19 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.0%. This expansion during the forecast period is primarily driven by factors such as the emergence of new infectious threats, an increasing focus on immunization registries, the rising threat of antimicrobial resistance, global efforts for pandemic preparedness, a shift toward personalized vaccines, and an increased focus on maternal immunization. Key trends for the forecast period include digital health integration, technological advancements in vaccine production, collaborations between governments and pharmaceutical companies, advancements in vaccine delivery technologies, and expanding immunization programs.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

What Factors Are Boosting The Adult Vaccines Market?

The adult vaccine market is being propelled forward by the increasing prevalence of contagious diseases, which are illnesses that spread from person to person. Vaccines are an effective mechanism for fighting infections as they help individuals develop immunity against these contagious diseases. For instance, in March 2023, the Centers for Disease Control and Prevention, a US-based national public health agency, reported that 8,300 tuberculosis cases were recorded in the United States in 2022, an increase from 7,874 in 2021. The incidence of TB during 2022 also saw a slight rise to 2.5 per 100,000 persons, compared with 2.4 during 2021. Therefore, the growing prevalence of contagious diseases is a key factor driving the expansion of the adult vaccine market.

How Is The Adult Vaccines Market Categorized By Application, Type, And Region?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

How Are Technological Trends Affecting The Adult Vaccines Market Growth?

Product innovations represent a key and increasingly popular trend within the adult vaccines market. Major companies operating in this sector are introducing novel products to secure their position. For example, in August 2022, GSK, a UK-based biopharma company, along with IQVIA, an India-based global provider of advanced analytics, technology solutions, and clinical research services, launched Vaccine Track. This data trend platform was created to help improve adult vaccination rates in communities nationwide. This resource is designed to provide frequent and relevant data on trends to guide and enhance public health efforts.

Who Are The Global Leaders Steering The Adult Vaccines Market Forward?

Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Adult Vaccines Market?

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp

Browse Through More Reports Similar to the Global Adult Vaccines Market 2025, By The Business Research Company

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Power Generators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Ventricular Assist Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795